UPDATE : Monday, September 7, 2020
상단여백
Qurient unveils P2a trial results for atopic dermatitis treatment in US by Lee Han-soo 2019-03-04 14:16
US trade agency begins probe into Medytox’s complaint about Daewoong by Lee Han-soo 2019-03-04 11:16
Bridge Biotherapeutics to accelerate global presence by Lee Han-soo 2019-03-04 10:50
Doctors, medical students struggled for Korea’s independence from Japanese colonialists by Lee Han-soo 2019-03-01 07:36
BioGenetics inks deal to supply biliary tract cancer drug in Korea by Lee Hye-seon 2019-02-28 16:49
라인
Hospitals still force new residents to pay ‘entry fee’ by Song Soo-youn 2019-02-28 16:47
GC starts P1 trials of hemophilia treatment by Lee Han-soo 2019-02-28 16:45
Bukwang to sell Novartis’ chronic hepatitis B treatment by Lee Han-soo 2019-02-28 14:59
‘Nurses were independence fighters during March 1 Movement’ by Lee Min-ju 2019-02-28 14:58
Chong Kun Dang topped clinical trials in 2018 by Lee Hye-seon 2019-02-28 10:50
라인
Korea, China to cooperate for regulations on drugs, medical devices, cosmetics by Lee Hye-seon 2019-02-27 22:41
Korea’s 30th novel drug K-Cab to get insurance benefit from March by Lee Hye-seon 2019-02-27 16:47
Korea to host annual Congress of Asian Society of Head and Neck Oncology by Lee Han-soo 2019-02-27 14:09
Korea’s drug exports hit record high in 2018, industry group says by Kim Yun-mi 2019-02-27 13:08
Korea to phase out consigned bioequivalence tests by Lee Hye-seon 2019-02-27 12:16
라인
National Cancer Center finds mechanism of cancer progression in osteosarcoma by Lee Han-soo 2019-02-27 11:09
Roche Diagnostics gets reimbursement for ALK diagnostic method by Lee Han-soo 2019-02-27 11:09
‘Multi-department treatment increases survival rate of liver cancer’ by Lee Han-soo 2019-02-26 17:01
GC unveils P1 results for hepatitis B treatment by Lee Han-soo 2019-02-26 16:07
‘Heat-not-burn cigarettes as risky as traditional ones’ by Kim Yun-mi 2019-02-26 15:45
여백
여백
여백
Back to Top